LIGAND PHARMACEUTICALS INCORPORATED Deferred Tax Liabilities, Investments
LIGAND PHARMACEUTICALS INCORPORATED (LGND) had Deferred Tax Liabilities, Investments of $2.94 million as of 2019-12-31, per its 10-K filed 2020-02-27.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Gross
us-gaap:DeferredTaxLiabilitiesInvestments · last filed 2020-02-27
- 2019-12-31: Deferred Tax Liabilities, Investments $2.94M.
- 2018-12-31: Deferred Tax Liabilities, Investments $2.48M.
- 2017-12-31: Deferred Tax Liabilities, Investments $0.00.
| Period end | Deferred Tax Liabilities, Investments |
|---|---|
| 2019-12-31 | $2.94M 10-K · filed 2020-02-27 |
| 2018-12-31 | $2.48M 10-K · filed 2020-02-27 |
| 2017-12-31 | $0.00 10-K · filed 2019-02-28 |